About Jeffrey Cleland
Jeffrey Cleland is an executive officer, director and promoter at Ironfist Therapeutics.
Form D filings also name Jeffrey Cleland as a director at Syncromune and Elixirgen Therapeutics and an executive officer, director and promoter at Nanopower Medicine.
Jeffrey Cleland first appears on SEC filings in 2022.
Experience
This experience comes from Jeffrey Cleland's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jeffrey Cleland in the role, so the role may have started earlier or lasted longer.
Ironfist Therapeutics, Inc. Current
Interim CEO, Co-Founder (2025 – Present)
Director
2025 – Present · Campbell, CA
PM
Programmable Medicine Current
Chairman, CEO & President
2025 – Present
SY
Syncromune® Current
Board Member
2022 – Present
AI
Ashvattha Therapeutics, Inc. Current
CEO, President & Co-Founder
2019 – Present
BO
Biotechnology Innovation Organization Current
Member, Governing Board
2014 – Present
Syncromune, Inc.
Director
2022 – 2026 · Fort Lauderdale, FL
Develops investigational immune therapies for people with metastatic solid tumors.
NS
Nativity Catholic School
Board Member / Founder Nativity School Development Fund
2012 – 2025
ZB
Zylem Biosciences
Board Member
2019 – 2023
EX
Exicure
Board Member
2019 – 2023
OI
Orpheris, Inc.
Executive Chairman
2015 – 2022
II
ImmunSys, Inc.
Board Member
2019 – 2020
GV
Graybug Vision
President & CEO
2016 – 2018
TI
Theraly Fibrosis, Inc.
Member Board Of Directors
2016 – 2018
VI
Versartis, Inc.
Founder & CEO
2015 – 2017
DP
Diartis Pharmaceuticals
CEO
2010 – 2013
PC
PDMDC (Consulting)
President, Founder
2003 – 2013
BI
BaroFold, Inc.
Vice President, Therapeutic Development
2007 – 2009
TE
Telik
Senior Director, Product Development
2005 – 2007
NI
Novacea, Inc
VP, Technical Operations
2003 – 2005
TA
Targesome
VP, R & D
2002 – 2003
Key Colleagues at Startups
The people Jeffrey Cleland works with at each company, as listed on that company's latest Form D.
Syncromune, Inc. · Form D/A, May 11, 2026
JG
Joseph Gerardi
Executive officer
Douglas Watson
Lead Independent Director
JM
Joseph Maroon
Director
Stephen Dale
Chief Medical Officer
NS
Norman Schwartz
Director
Charles Link
Executive Chairman & Chief Innovation Officer
Eamonn Hobbs
President & Chief Executive Officer, director
Kerri-Ann Millar
Chief Financial Officer
Agustin Gago
Chief Operating Officer
Elixirgen Therapeutics, Inc. · Form D, Nov 13, 2025
HK
Hiroaki Kobayashi
Director
TW
Thomas White
Director
MK
Minoru Ko
Director
SC
Shauna Callahan
Director
AK
Akihiro Ko
CEO and director
Ironfist Therapeutics, Inc. · Form D, Oct 20, 2025
JZ
Jay Zaveri
Executive officer, director and promoter
AS
Arjun Sethi
Executive officer, director and promoter
Nanopower Medicine, Inc. · Form D, Oct 20, 2025
AS
Arjun Sethi
Executive officer, director and promoter
JZ
Jay Zaveri
Executive officer, director and promoter